HRTX
USDHeron Therapeutics Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$1.170
고가
$1.190
저가
$1.070
거래량
1.54M
기업 기본 정보
시가총액
202.6M
산업
생명공학
국가
United States
거래 통계
평균 거래량
1.92M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 millionZYNRELEF® Net
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
CARY, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call
관련 주식
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기